glioma
We have investigated the role of myosin II in glioma motility and invasiveness by examining the effects of two inhibitors of myosin light chain kinase, ML7 and KT5926.
We have investigated the role of myosin II in <span class="disease" id="10232591-5-46-52">glioma</span> motility and invasiveness by examining the effects of two inhibitors of <span class="gene" id="10232591-5-125-150">myosin light chain kinase</span>, ML7 and KT5926.